TC BioPharm【TCBP】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
TC BioPharm Holdings PLC (TCBP) 銘柄情報

TC BioPharm Holdings PLC (TCBP)

7.59

0.98

(14.83%)

終了 10月6日 5:00AM

7.225

-0.365

(-4.81%)

取引時間後: 8:52AM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

7.225

買値

7.22

売値

7.65

出来高

375,641

6.8016 日の範囲 7.75

0.00 52 週間の範囲 0.00

時価総額

前日終値

6.61

始値

7.00

時刻

最終取引時間

財務取引量

US$ 2,730,122

VWAP

7.2679

平均取引量 (3 か月)

-

発行済株式数

582,020

配当利回り

-

PER

-0.75

1 株当たり利益 (EPS)

-10.15

歳入

-

純利益

-5.91M

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

セクター

Coml Physical, Biologcl Resh

業界

Coml Physical, Biologcl Resh

ウェブサイト

www.tcbiopharm.com

本社

Scotland, Gbr

設立

-

TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the ナスダック市場 with ticker TCBP. The last closing price for TC BioPharm was US$6.61. Over the last year, TC BioPharm shares have traded in a share price range of US$ 0.00 to US$ 0.00.

TC BioPharm currently has 582,020 shares in issue. The market capitalisation of TC BioPharm is US$3.85 million. TC BioPharm has a price to earnings ratio (PE ratio) of -0.75.

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...

TCBP Announces Site Opening of Guys and St. Thomas Hospital

TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...

TCBP to Present at the 2024 ThinkEquity Conference in NYC

TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

/C O R R E C T I O N -- TC BioPharm/

/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 No TCB008-related Adverse Events seen in any of the re-start...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9, 2024 EDINBURGH, Scotland, Sept. 9, 2024 /PRNewswire/ -- TC BioPharm...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 6, 2024 EDINBURGH, Scotland, Sept. 6, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland, Sept. 5, 2024 EDINBURGH, Scotland, Sept. 5, 2024 /PRNewswire/ -- TC...

TCBP Announces Dosing of 5 New Patients in ACHIEVE

TCBP Announces Dosing of 5 New Patients in ACHIEVE PR Newswire EDINBURGH, Scotland, Sept. 3, 2024 5 New patients dosed, bringing total to 6 patients dosed in ACHIEVE at higher dose level5...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...

TCBP Announces Site Opening of Guys and St. Thomas Hospital

TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...

TCBP to Present at the 2024 ThinkEquity Conference in NYC

TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

/C O R R E C T I O N -- TC BioPharm/

/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 No TCB008-related Adverse Events seen in any of the re-start...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9, 2024 EDINBURGH, Scotland, Sept. 9, 2024 /PRNewswire/ -- TC BioPharm...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 6, 2024 EDINBURGH, Scotland, Sept. 6, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland, Sept. 5, 2024 EDINBURGH, Scotland, Sept. 5, 2024 /PRNewswire/ -- TC...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CHSNChanson International Holding	US$ 11.22 (269.08%)	14.76M
PEVPhoenix Motor Inc	US$ 1.0607 (205.24%)	228.42M
ENTOEntero Therapeutics Inc	US$ 0.60 (72.20%)	10.42M
BENFBeneficient	US$ 1.8914 (58.94%)	108.31M
FORDForward Industries Inc	US$ 5.3254 (52.15%)	18.45M
ADDColor Star Technology Company Ltd	US$ 0.2701 (-39.98%)	15.01M
DUOFangDD Network Group Ltd	US$ 2.53 (-32.89%)	28.52M
ICCTiCoreConnect Inc	US$ 0.4102 (-31.50%)	1.68M
ZENAZenaTech Inc	US$ 3.91 (-29.55%)	213.24k
SPAISafe Pro Group Inc	US$ 1.93 (-25.77%)	239.89k
NVDANVIDIA Corporation	US$ 124.92 (1.68%)	244.46M
PEVPhoenix Motor Inc	US$ 1.0607 (205.24%)	228.42M
SQQQProShares UltraPro Short QQQ	US$ 7.43 (-3.63%)	184.47M
NCNCnoco noco Inc	US$ 0.144 (8.60%)	147.38M
BENFBeneficient	US$ 1.8914 (58.94%)	108.31M

Monksdream

Monksdream 4週前

glenn1919

glenn1919 4週前

TCBP.............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783

moondogaz

moondogaz 4週前

Don't see it...but I hope you squeeze a few more out of it.

glens0

TCBP 7.50 made the list, she should squeeze big soon
https://www.nasdaqtrader.com/trader.aspx?id=regshothreshold

moondogaz

moondogaz 1月前

glens0

TCBP going back up
I made some money on it yesterday. Trying to make more today

moondogaz

moondogaz 1月前

Ain't lookn beastly.

TrendTrade2016

TrendTrade2016 1月前

TrendTrade2016

TrendTrade2016 1月前

Invest-in-America

Invest-in-America 1月前

TCBPW: Watch the WARRANTS here exit our Galaxy today!!

TrendTrade2016

TrendTrade2016 1月前

TCBP..LOW VOLUME BEAST

glenn1919

glenn1919 1月前

TCBP.....................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783

peterus

peterus 1月前

break 6s and she will blow up

peterus

peterus 1月前

halt ip up 5.50s

peterus

peterus 1月前

stoploss at 5.02s

ollik78

ollik78 1月前

Out at 5.
What a nice evening!
Thanks again

ollik78

ollik78 1月前

TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications

peterus

peterus 1月前

ollik78

ollik78 1月前

And there it is! Gratulation.
Thanks

peterus

peterus 1月前

ollik78

ollik78 1月前

peterus

peterus 1月前

boom coming shortie

ollik78

ollik78 1月前

Ok thanks!
Will add some in my basket.

peterus

peterus 1月前

back in should get approval European patent the 28 aug

Monksdream

Monksdream 2月前

TCBP new 52 week low

ollik78

ollik78 2月前

Good to know.
Just on the sideline

peterus

peterus 2月前

sold this turd yesterday 0.92s

ollik78

ollik78 2月前

PR and price drops

peterus

peterus 2月前

need a pr from the company

Dyno89

European patent GRANTED!

https://register.epo.org/application?number=EP16721208

peterus

peterus 2月前

this pos should run AH or tmrw

SeniorApollo

SeniorApollo 4月前

Was there news that I missed?

moneydreamer

moneydreamer 4月前

Thank you so much and good luck$$$

surf1944

surf1944 4月前

TCBP has had so many price spikes over the month few months it has been a profitable trade to buy after weakness, I have a full position currently.

moneydreamer

moneydreamer 4月前

Do you think it’s time to buy? I am new here

Monksdream

Monksdream 4月前

surf1944

surf1944 5月前

https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Bottom bounce coming!

Awl416

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

glenn1919

glenn1919 6月前

TCBP...............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 6月前

Will it grow legs after 9:30

Awl416

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

Awl416

Smells in here given that volume of 130m

Invest-in-America

Invest-in-America 7月前

TCBP: But, nobody interested --- whatever works.

surf1944

surf1944 7月前

https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Chart bounce candidate!

Monksdream

Monksdream 7月前

TCBP new 52 week low

EyalCap

EyalCap 7月前

$TCBP The acceptance of TC BioPharm’s amendment by the MHRA for the ACHIEVE UK trial can be seen as a bullish signal for several reasons:

1. Enhanced Trial Flexibility: The ability to increase the dose level for TCB008 and shift to an outpatient procedure may improve the trial’s efficiency and patient experience. This flexibility could potentially lead to better trial outcomes and patient adherence.
2. Operational Efficiency: Reducing the need for overnight hospital stays for patients after dosing not only improves the quality of life for participants but also eases the burden on clinical sites. This operational efficiency can accelerate the trial’s progress.
3. Positive Regulatory Feedback: Gaining regulatory acceptance for amendments suggests a positive interaction between TC BioPharm and regulatory bodies, indicating that the company is responsive and adaptable to both regulatory requirements and clinical insights.
4. Potential Impact on FDA Trial: The amendments align with the dosing levels of the Investigational New Drug (IND) application for the second cohort, which might streamline the process for the FDA trial. This proactive approach to aligning international trial standards may facilitate smoother regulatory negotiations and trial implementations in multiple jurisdictions.
5. Innovative Treatment Potential: The focus on TCB008 and its application in treating Acute Myeloid Leukemia (AML) underscores TC BioPharm’s commitment to developing innovative cancer treatments. Success in these trials could position the company as a leader in gamma-delta T cell therapies, potentially opening up significant market opportunities.

elks

Chart bottom looks like.

glenn1919

glenn1919 8月前

TCBP..................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783

elks

I want double digits

londonohoyos

londonohoyos 8月前

How high might it go

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約